» Articles » PMID: 18282772

Enhancing and Maintaining Chondrogenesis of Synovial Fibroblasts by Cartilage Extracellular Matrix Protein Matrilins

Overview
Date 2008 Feb 20
PMID 18282772
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Cartilage-specific extracellular matrix (ECM) proteins have been proposed to play key roles in modulating cellular phenotypes during chondrogenesis of mesenchymal stem cells. Matrilin (MATN)1 and MATN3 are among the most up-regulated ECM proteins during chondrogenesis. The aim of this study was to analyze their roles in chondrogenesis of mesenchymal fibroblasts from synovium.

Methods: Primary synovial fibroblasts (SFBs) were purified from porcine synovium and incubated in pellet culture for 18 days. Chondrogenesis of SFB was analyzed by histological staining with safranin-O/fast green, and by quantifying glycosaminoglycans (GAG) with dimethylmethylene blue assay. The mRNA levels of chondrogenic markers including collagen II, aggrecan, and Sox 9 were quantified by real-time reverse transcription polymerase chain reaction, while the protein levels of Col II and MATNs were determined by western blot analysis.

Results: SFBs underwent chondrogenesis after incubation with transforming growth factor-beta1 (TGF-beta1) for 3 days; however, this process was attenuated during the subsequent incubation period. Expression of a Matn1 or Matn3 cDNA maintained and further enhanced chondrogenesis of SFBs as shown by increased cartilaginous matrix areas, elevated amount of GAG, and stimulated expression of chondrogenic markers.

Conclusion: Our findings suggest a novel function for MATN1 and MATN3 to maintain and enhance chondrogenesis of mesenchymal fibroblasts initiated by TGF-beta. Our results also support a critical role of cartilage-specific ECM proteins to modulate cellular phenotypes in the microenvironment during chondrogenic differentiation.

Citing Articles

Nanoscale Morphologies on the Surface of Substrates/Scaffolds Enhance Chondrogenic Differentiation of Stem Cells: A Systematic Review of the Literature.

Xiao Y, Yang S, Sun Y, Sah R, Wang J, Han C Int J Nanomedicine. 2024; 19:12743-12768.

PMID: 39634196 PMC: 11615010. DOI: 10.2147/IJN.S492020.


MATN3 delivered by exosome from synovial mesenchymal stem cells relieves knee osteoarthritis: Evidence from and studies.

Long L, Zou G, Cheng Y, Li F, Wu H, Shen Y J Orthop Translat. 2023; 41:20-32.

PMID: 37635810 PMC: 10448336. DOI: 10.1016/j.jot.2023.06.003.


Suppressing Chondrocyte Hypertrophy to Build Better Cartilage.

Shigley C, Trivedi J, Meghani O, Owens B, Jayasuriya C Bioengineering (Basel). 2023; 10(6).

PMID: 37370672 PMC: 10295138. DOI: 10.3390/bioengineering10060741.


Growth plate extracellular matrix defects and short stature in children.

Saltarelli M, Quarta A, Chiarelli F Ann Pediatr Endocrinol Metab. 2022; 27(4):247-255.

PMID: 36567461 PMC: 9816467. DOI: 10.6065/apem.2244120.060.


Fabrication and Characterization of Layer-by-Layer Janus Base Nano-Matrix to Promote Cartilage Regeneration.

Landolina M, Yau A, Chen Y J Vis Exp. 2022; (185).

PMID: 35876554 PMC: 10149039. DOI: 10.3791/63984.


References
1.
Takeuchi Y, Kodama Y, Matsumoto T . Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. J Biol Chem. 1994; 269(51):32634-8. View

2.
Pacifici M, Koyama E, Iwamoto M, Gentili C . Development of articular cartilage: what do we know about it and how may it occur?. Connect Tissue Res. 2001; 41(3):175-84. DOI: 10.3109/03008200009005288. View

3.
ODriscoll S, Fitzsimmons J . The role of periosteum in cartilage repair. Clin Orthop Relat Res. 2001; (391 Suppl):S190-207. DOI: 10.1097/00003086-200110001-00019. View

4.
Hocking A, Shinomura T, McQuillan D . Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol. 1998; 17(1):1-19. DOI: 10.1016/s0945-053x(98)90121-4. View

5.
Zimmermann T, Kunisch E, Pfeiffer R, Hirth A, Stahl H, Sack U . Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture--primary culture cells markedly differ from fourth-passage cells. Arthritis Res. 2001; 3(1):72-6. PMC: 17827. DOI: 10.1186/ar142. View